Premium
Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID‐19: coincidence or underestimated risk factor?
Author(s) -
Luxenburger H.,
Sturm L.,
Biever P.,
Rieg S.,
Duerschmied D.,
Schultheiss M.,
NeumannHaefelin C.,
Thimme R.,
Bettinger D.
Publication year - 2021
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/joim.13121
Subject(s) - medicine , ards , pneumonia , risk factor , proton pump inhibitor , medical record , covid-19 , disease , intensive care medicine , pediatrics , lung , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom